SquareMind, an AI and robotics firm growing options for dermatology, has introduced $18 million in funding, together with beforehand undisclosed pre-Sequence A financing, to allow high-quality, constant pores and skin exams and make them accessible at scale.
The spherical was led by Sonder Capital, a California-based enterprise fund co-founded by medical robotics pioneer and Intuitive Surgical founder Fred Moll, with participation by the Deeptech 2030 Fund, managed on behalf of the French authorities by a Bpifrance initiative, Adamed Expertise, Calm/Storm Ventures, Teampact Ventures, and several other outstanding entrepreneurs.
The funding will assist the expansion of the corporate’s business, engineering, and buyer assist groups in preparation for a near-term business launch of the Swan robotic pores and skin imaging platform in the US and Europe, the place demand for pores and skin exams is excessive and rising.
Pores and skin screening is the number-one quantity process in dermatology and demand continues to outpace capability as a consequence of a quickly growing older inhabitants involved with skincare, with waitlists stretching months.
Time constraints depart little room for thorough documentation, which is necessary for early detection as 80 p.c of melanomas – a deadly pores and skin most cancers – are new lesions.
“We’re excited to associate with Sonder Capital and all our buyers as we prepared ourselves to convey Swan to market and reply to the robust traction we’re seeing from practices and hospitals,” mentioned Ali Khachlouf, co-founder and CEO of SquareMind.
“Dermatologists are working below growing stress, going through robust cognitive load and fatigue. Our know-how acts as their companion, serving to to scale back this burden, optimize their time, and assist complete documentation to allow them to keep targeted on affected person care and scientific decision-making.”
Robotics and AI designed to assist dermatologists at scale
Developed in collaboration with main dermatologists, Swan is the world’s first robotic to seize standardized, full-body dermoscopic pores and skin imaging, appearing as an augmented dermatoscope to supply a view of your complete pores and skin floor at a degree usually obtained when analyzing moles up shut.
Picture acquisition is automated, accomplished in simply minutes, and seamlessly integrates into scientific workflows.
Swan is paired with AI-based software program supporting the assessment of pores and skin imaging to assist observe new or altering moles over time, whereas physicians retain full scientific judgment.
“We basically imagine that advances in AI and medical robotics will reshape medical apply by automating routine procedures, optimizing scientific time, and increasing entry to high-quality care,” mentioned Kate Garrett, managing associate at Sonder Capital.
“SquareMind has developed a very distinctive platform that has the potential to develop into the worldwide normal of care in trendy dermatology.”
The Swan expertise
In a non-public examination room, the affected person stands earlier than the Swan robotic and is guided by visible and audio prompts whereas the robotic arm gracefully strikes round them capturing pictures of their pores and skin. The session is “quick and contactless, making certain a cushty affected person expertise”, says the corporate.
